Thermo Fisher (TMO) Gets a Buy from Stifel Nicolaus
In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Thermo Fisher, with a price target of $700.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arias covers the Healthcare sector, focusing on stocks such as Exact Sciences, Thermo Fisher, and Illumina. According to TipRanks, Arias has an average return of 2.3% and a 49.47% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Thermo Fisher with a $658.89 average price target.
Based on Thermo Fisher’s latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $11.12 billion and a net profit of $1.62 billion. In comparison, last year the company earned a revenue of $10.6 billion and had a net profit of $1.63 billion
Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TMO in relation to earlier this year. Last month, Michel Lagarde, the EVP & COO of TMO sold 22,046.00 shares for a total of $12,424,243.76.
Read More on TMO:
Disclaimer & DisclosureReport an Issue
- Thermo Fisher price target raised to $696 from $654 at TD Cowen
- Thermo Fisher price target raised to $650 from $610 at Evercore ISI
- Thermo Fisher price target raised to $700 from $650 at BofA
- Thermo Fisher price target raised to $675 from $635 at Wells Fargo
- PayPal downgraded, Roku upgraded: Wall Street’s top analyst calls
